Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changgui Li

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
BMJ Open|November 7, 2024
Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohortSarah Stewart, Greg Gamble, William Taylor, et al.
Biological Psychiatry|June 28, 2024
The Contribution of Mosaic Chromosomal Alterations to SchizophreniaKaihui Chang, Xuemin Jian, Chuanhong Wu, et al.
The Pediatric Infectious Disease Journal|February 18, 2026
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b TrialLingxian Qiu, Hongxing Pan, Qi Liang, et al.
The Lancet. Infectious Diseases|March 27, 2021
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsShilong Yang, Yan Li, Lianpan Dai, et al.
The Journal of Infectious Diseases|August 8, 2018
Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old ChildrenYan Liang, Yanchun Che, Beifang Yang, et al.
Cell Discovery|October 21, 2024
NUMB dysfunction defines a novel mechanism underlying hyperuricemia and goutJingwei Chi, Ying Chen, Changgui Li, et al.
The New England Journal of Medicine|May 4, 2022
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in AdultsLianpan Dai, Lidong Gao, Lifeng Tao, et al.
Cell|August 12, 2020
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2Hui Wang, Yuntao Zhang, Baoying Huang, et al.
International Journal of Rheumatic Diseases|July 22, 2025
2024 Update of Chinese Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout Part I: Recommendations for General PatientsMingshu Sun, Zhaohui Lyu, Can Wang, et al.
The Lancet. Respiratory Medicine|June 1, 2022
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trialsFengcai Zhu, Chunlan Zhuang, Kai Chu, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
BMJ Open|November 7, 2024
Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohortSarah Stewart, Greg Gamble, William Taylor, et al.
Biological Psychiatry|June 28, 2024
The Contribution of Mosaic Chromosomal Alterations to SchizophreniaKaihui Chang, Xuemin Jian, Chuanhong Wu, et al.
The Pediatric Infectious Disease Journal|February 18, 2026
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b TrialLingxian Qiu, Hongxing Pan, Qi Liang, et al.
The Lancet. Infectious Diseases|March 27, 2021
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsShilong Yang, Yan Li, Lianpan Dai, et al.
The Journal of Infectious Diseases|August 8, 2018
Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old ChildrenYan Liang, Yanchun Che, Beifang Yang, et al.
Cell Discovery|October 21, 2024
NUMB dysfunction defines a novel mechanism underlying hyperuricemia and goutJingwei Chi, Ying Chen, Changgui Li, et al.
The New England Journal of Medicine|May 4, 2022
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in AdultsLianpan Dai, Lidong Gao, Lifeng Tao, et al.
Cell|August 12, 2020
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2Hui Wang, Yuntao Zhang, Baoying Huang, et al.
International Journal of Rheumatic Diseases|July 22, 2025
2024 Update of Chinese Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout Part I: Recommendations for General PatientsMingshu Sun, Zhaohui Lyu, Can Wang, et al.
The Lancet. Respiratory Medicine|June 1, 2022
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trialsFengcai Zhu, Chunlan Zhuang, Kai Chu, et al.
Pageof 26